102 related articles for article (PubMed ID: 24397032)
21. Synthesis and biological evaluation of conjugates of deoxypodophyllotoxin and 5-FU as inducer of caspase-3 and -7.
Huang WT; Liu J; Liu JF; Hui L; Ding YL; Chen SW
Eur J Med Chem; 2012 Mar; 49():48-54. PubMed ID: 22244588
[TBL] [Abstract][Full Text] [Related]
22. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
Cho YW; Lee JR; Song SC
Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
[TBL] [Abstract][Full Text] [Related]
23. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.
Abd-Rabou AA; Bharali DJ; Mousa SA
Pharm Res; 2018 Feb; 35(4):76. PubMed ID: 29488022
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
Daumar P; Decombat C; Chezal JM; Debiton E; Madesclaire M; Coudert P; Galmier MJ
Eur J Med Chem; 2011 Jul; 46(7):2867-79. PubMed ID: 21530016
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines.
Núñez MC; Díaz-Gavilán M; Conejo-García A; Cruz-López O; Gallo MA; Espinosa A; Campos JM
Curr Med Chem; 2008; 15(25):2614-31. PubMed ID: 18855682
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonates.
Jhansi Rani V; Raghavendra A; Kishore P; Nanda Kumar Y; Hema Kumar K; Jagadeeswarareddy K
Eur J Med Chem; 2012 Aug; 54():690-6. PubMed ID: 22796042
[TBL] [Abstract][Full Text] [Related]
27. Antitumor and antiangiogenic active dendrimer/5-fluorouracil conjugates.
Lee SM; Bala YS; Lee WK; Jo NJ; Chung I
J Biomed Mater Res A; 2013 Aug; 101(8):2306-12. PubMed ID: 23355500
[TBL] [Abstract][Full Text] [Related]
28. 1-Alkylcarbonyloxymethyl prodrugs of 5-fluorouracil (5-FU): synthesis, physicochemical properties, and topical delivery of 5-FU.
Taylor HE; Sloan KB
J Pharm Sci; 1998 Jan; 87(1):15-20. PubMed ID: 9452962
[TBL] [Abstract][Full Text] [Related]
29. Molecular insights on the cyclic peptide nanotube-mediated transportation of antitumor drug 5-fluorouracil.
Liu H; Chen J; Shen Q; Fu W; Wu W
Mol Pharm; 2010 Dec; 7(6):1985-94. PubMed ID: 20964368
[TBL] [Abstract][Full Text] [Related]
30. 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties.
Kaiser N; Kimpfler A; Massing U; Burger AM; Fiebig HH; Brandl M; Schubert R
Int J Pharm; 2003 Apr; 256(1-2):123-31. PubMed ID: 12695018
[TBL] [Abstract][Full Text] [Related]
31. Prodrugs of 5-fluorouracil. V. 1-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluorouracil.
Buur A; Bundgaard H
J Pharm Sci; 1986 May; 75(5):522-7. PubMed ID: 3735094
[TBL] [Abstract][Full Text] [Related]
32. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
[TBL] [Abstract][Full Text] [Related]
33. Twisted amide reduction under Wolff-Kishner conditions: synthesis of a benzo-1-aza-adamantane derivative.
Bashore CG; Samardjiev IJ; Bordner J; Coe JW
J Am Chem Soc; 2003 Mar; 125(11):3268-72. PubMed ID: 12630882
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of new 5-fluorouracil antitumor cell differentiating derivatives.
Domínguez JF; Marchal JA; Correa A; Carrillo E; Boulaiz H; Aránega A; Gallo MA; Espinosa A
Bioorg Med Chem; 2003 Feb; 11(3):315-23. PubMed ID: 12517427
[TBL] [Abstract][Full Text] [Related]
35. Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.
Legay R; Massou S; Azéma J; Martino R; Malet-Martino M
J Pharm Biomed Anal; 2014 Sep; 98():446-62. PubMed ID: 25038499
[TBL] [Abstract][Full Text] [Related]
36. Encapsulation and Systemic Delivery of 5-Fluorouracil Conjugated with Silkworm Pupa Derived Protein Nanoparticles for Experimental Lymphoma Cancer.
Reneeta NP; Thiyonila B; Aathmanathan VS; Ramya T; Chandrasekar P; Subramanian N; Prajapati VK; Krishnan M
Bioconjug Chem; 2018 Sep; 29(9):2994-3009. PubMed ID: 30089206
[TBL] [Abstract][Full Text] [Related]
37. 5-Fluorouracil derivatives. XX. Synthesis and antitumor activity of 5'-O-unsaturated acyl-5-fluorouridines.
Ozaki S; Akiyama T; Morita T; Kumegawa M; Nagase T; Uehara N; Hoshi A
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3164-6. PubMed ID: 2085902
[TBL] [Abstract][Full Text] [Related]
38. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and release of 5-fluorouracil from poly(N-vinylpyrrolidinone) bearing 5-fluorouracil derivatives.
Liu Z; Rimmer S
J Control Release; 2002 May; 81(1-2):91-9. PubMed ID: 11992682
[TBL] [Abstract][Full Text] [Related]
40. Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.
Al Sabbagh C; Tsapis N; Novell A; Calleja-Gonzalez P; Escoffre JM; Bouakaz A; Chacun H; Denis S; Vergnaud J; Gueutin C; Fattal E
Pharm Res; 2015 May; 32(5):1585-603. PubMed ID: 25416027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
